INTERNATIONAL SOCIETY FOR PHARMACE… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1995

Legal Domicile

Phone

9493879046

Tax Period

2025-01-01 to 2025-12-31

INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC SAN DIEGO CHAPTER, founded in 1995, is a small nonprofit that reported $418K in total revenue in fiscal year 2025. Revenue surged 21% from the prior year, signaling strong growth momentum. The organization ran a surplus of $155K, a strong 37% operating margin.

Mission

SCIENTIFIC PROFESSIONAL MEMBERSHIP ORGANIZATION.

Program Service Accomplishments

Program 1

QUARTERLY MEETINGS WITH GUEST SPEAKERS, SPONSORING ANNUAL VENDOR NITE EVENT. THESE ACTIVITIES PROMOTE THE SOCIETY'S GOALS OF EXCHANGING INFORMATION WITH ALL MEMBERS KEEPING THEM CURRENT ON...

QUARTERLY MEETINGS WITH GUEST SPEAKERS, SPONSORING ANNUAL VENDOR NITE EVENT. THESE ACTIVITIES PROMOTE THE SOCIETY'S GOALS OF EXCHANGING INFORMATION WITH ALL MEMBERS KEEPING THEM CURRENT ON STATE-OF-THE-ART TECHNOLOGY AND TRENDS.ISSUED MONTHLY NEWSLETTER TO FURTHER MEMBERS' KNOWLEDGE, PROVIDE SCHEDULE OF LOCAL AND OTHER INDUSTRY MEETINGS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $389,980

Investment Income $0

Other Revenue $27,785

TOTAL REVENUE $417,765

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $262,825

TOTAL EXPENSES $262,825

Year-over-Year Comparison

	2025	2024	Change
Revenue	$417,765	$344,640	+0.2%
Expenses	$262,825	$278,287	-0.1%
Net Income	$154,940	$66,353	+1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SHANNON CHESTERFIELD	President	2.00	Director	$0	$0	$0
RICK JAENISCH	Vice President	2.00	Director	$0	$0	$0
TOM HUNG	Treasurer	2.00	Director	$0	$0	$0
ANNE LYNCH	Secretary	2.00	Director	$0	$0	$0
LAURA ELLERY	SOCIAL PROGRAM	2.00	Director	$0	$0	$0
NICK REIKOW	TECHNICAL PROGR	2.00	Director	$0	$0	$0
SAYA GODWIN	WOMEN IN PHARMA	2.00	Director	$0	$0	$0
JARED OLSON	EMERGING LEADER	2.00	Director	$0	$0	$0
NOAH POPICK	STUDENT AFFAIRS	2.00	Director	$0	$0	$0
ERICA WELKER	EXPO	2.00	Director	$0	$0	$0
MICHELLE LACOMBE	MEMBERSHIP	2.00	Director	$0	$0	$0
LAURA SCULLY	COMMUNICATIONS	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$417,765	$262,825	$452,489	$154,940
2024	$344,640	$278,287	$300,854	$66,353
2023	$300,106	$229,243	$232,566	$70,863
2019	$203,605	$173,995	$197,294	$29,610

INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC SAN DIEGO CHAPTER